BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28186381)

  • 1. Psychiatric and psychological aspects in the Ehlers-Danlos syndromes.
    Bulbena A; Baeza-Velasco C; Bulbena-Cabré A; Pailhez G; Critchley H; Chopra P; Mallorquí-Bagué N; Frank C; Porges S
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):237-245. PubMed ID: 28186381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome/hypermobile Ehlers Danlos syndrome.
    Engelbert RH; Juul-Kristensen B; Pacey V; de Wandele I; Smeenk S; Woinarosky N; Sabo S; Scheper MC; Russek L; Simmonds JV
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):158-167. PubMed ID: 28306230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermobility, the Ehlers-Danlos syndromes and chronic pain.
    Syx D; De Wandele I; Rombaut L; Malfait F
    Clin Exp Rheumatol; 2017; 35 Suppl 107(5):116-122. PubMed ID: 28967365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.
    Tinkle B; Castori M; Berglund B; Cohen H; Grahame R; Kazkaz H; Levy H
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):48-69. PubMed ID: 28145611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low- and high-anxious hypermobile Ehlers-Danlos syndrome patients: comparison of psychosocial and health variables.
    Baeza-Velasco C; Bourdon C; Montalescot L; de Cazotte C; Pailhez G; Bulbena A; Hamonet C
    Rheumatol Int; 2018 May; 38(5):871-878. PubMed ID: 29497845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopathological manifestations of joint hypermobility and joint hypermobility syndrome/ Ehlers-Danlos syndrome, hypermobility type: The link between connective tissue and psychological distress revised.
    Sinibaldi L; Ursini G; Castori M
    Am J Med Genet C Semin Med Genet; 2015 Mar; 169C(1):97-106. PubMed ID: 25821094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An acquired or heritable connective tissue disorder? A review of hypermobile Ehlers Danlos Syndrome.
    Martin A
    Eur J Med Genet; 2019 Jul; 62(7):103672. PubMed ID: 31102747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updates on the psychological and psychiatric aspects of the Ehlers-Danlos syndromes and hypermobility spectrum disorders.
    Bulbena-Cabré A; Baeza-Velasco C; Rosado-Figuerola S; Bulbena A
    Am J Med Genet C Semin Med Genet; 2021 Dec; 187(4):482-490. PubMed ID: 34806831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular autonomic dysfunction in Ehlers-Danlos syndrome-Hypermobile type.
    Hakim A; O'Callaghan C; De Wandele I; Stiles L; Pocinki A; Rowe P
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):168-174. PubMed ID: 28160388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know.
    Thwaites PA; Gibson PR; Burgell RE
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1693-1709. PubMed ID: 35750466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory.
    Bennett SE; Walsh N; Moss T; Palmer S
    Disabil Rehabil; 2022 Sep; 44(18):5231-5240. PubMed ID: 34101520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of pain and mobility disability in the hypermobile Ehlers-Danlos syndrome.
    Kalisch L; Hamonet C; Bourdon C; Montalescot L; de Cazotte C; Baeza-Velasco C
    Disabil Rehabil; 2020 Dec; 42(25):3679-3686. PubMed ID: 31060411
    [No Abstract]   [Full Text] [Related]  

  • 13. Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Zoppi N; Chiarelli N; Binetti S; Ritelli M; Colombi M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1010-1023. PubMed ID: 29309923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin biopsy reveals generalized small fibre neuropathy in hypermobile Ehlers-Danlos syndromes.
    Igharo D; Thiel JC; Rolke R; Akkaya M; Weis J; Katona I; Schulz JB; Maier A
    Eur J Neurol; 2023 Mar; 30(3):719-728. PubMed ID: 36437696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the beliefs, needs, and expectations for genetic counseling of patients with hypermobile Ehlers-Danlos syndrome.
    Ahimaz P; Kramer T; Swaroop P; Mitchell M; Hernan R; Anyane-Yeboa K; Pereira EM
    Am J Med Genet A; 2022 Nov; 188(11):3172-3183. PubMed ID: 36209348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Italian validation of the functional difficulties questionnaire (FDQ-9) and its correlation with major determinants of quality of life in adults with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorder.
    Morlino S; Dordoni C; Sperduti I; Clark CJ; Piedimonte C; Fontana A; Colombi M; Grammatico P; Copetti M; Castori M
    Am J Med Genet B Neuropsychiatr Genet; 2019 Jan; 180(1):25-34. PubMed ID: 30471081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermobile Ehlers-Danlos syndrome: A review and a critical appraisal of published genetic research to date.
    Scicluna K; Formosa MM; Farrugia R; Borg I
    Clin Genet; 2022 Jan; 101(1):20-31. PubMed ID: 34219226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom complaints and impact on functioning in youth with hypermobile Ehlers-Danlos syndrome.
    Tran ST; Jagpal A; Koven ML; Turek CE; Golden JS; Tinkle BT
    J Child Health Care; 2020 Sep; 24(3):444-457. PubMed ID: 31370685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cell activation disease and immunoglobulin deficiency in patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorder.
    Brock I; Prendergast W; Maitland A
    Am J Med Genet C Semin Med Genet; 2021 Dec; 187(4):473-481. PubMed ID: 34747107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hypermobile Ehlers-Danlos syndrome in postural orthostatic tachycardia syndrome.
    Miller AJ; Stiles LE; Sheehan T; Bascom R; Levy HP; Francomano CA; Arnold AC
    Auton Neurosci; 2020 Mar; 224():102637. PubMed ID: 31954224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.